A hospital management algorithm for acute poisoning by Paraquat® in a pediatric population, a series of cases
Alejandro Padilla-GuzmánOlga L PradoDavid BallesterosViviana RiveraYessica BravoLuisa MurilloSandra NarváezJessica María Forero-DelgadilloPublished in: Biomedica : revista del Instituto Nacional de Salud (2024)
Paraquat®, or N,N′-dimethyl-4,4′-bipyridinium dichloride, is a bipyridyl compound used as a non-selective herbicide and desiccant that can cause acute poisoning through all routes of exposure. There is no known antidote, and the available treatments are based on avoiding its absorption and timely removing it, in adults and children. We describe a case series of 14 pediatric patients from the department of Cauca, Colombia, with acute intoxication after oral intake of paraquat. Patients were referred to a medium-high complexity hospital in southwestern Colombia and treated according to an institutional protocol for acute paraquat poisoning. Acute paraquat poisoning after oral ingestion is associated with a high mortality rate, even with timely medical attention, as the compound has no known antidote and quickly reaches systemic concentrations for fulminant poisoning. Based on the available literature, our center has proposed a clinical protocol including early standard management, immunosuppressive and antioxidant treatments, and systemic removal techniques. This protocol suggests an adequate approach to acute paraquat poisoning in the pediatric population.
Keyphrases
- liver failure
- respiratory failure
- drug induced
- aortic dissection
- healthcare
- randomized controlled trial
- systematic review
- end stage renal disease
- pulmonary fibrosis
- newly diagnosed
- intensive care unit
- type diabetes
- chronic kidney disease
- young adults
- oxidative stress
- emergency department
- deep learning
- ejection fraction
- prognostic factors
- peritoneal dialysis
- working memory
- extracorporeal membrane oxygenation
- tertiary care
- weight loss
- weight gain
- acute respiratory distress syndrome
- adverse drug
- neural network